The listing process of China Medical and Health Products Co., Ltd.

With the approval of China Securities Regulatory Commission (CSRC) Fa Zi [1997]No. 164 and Fa Zi [1997]No. 165, the company publicly issued 30 million RMB ordinary shares on April 28, 2007, including 20 million shares to the public. After this issuance, the registered capital of the company is 65.438+0.20 billion yuan, of which 90 million shares are state-owned legal person shares, which are held by China Technology Import and Export Corporation. There are 30 million public shares listed on the Shanghai Stock Exchange.

According to the Reply of China Securities Regulatory Commission on the Application of China Technology Trading Co., Ltd. (Zheng Jian Zi [2000] 162), in 2000, the company allocated10.35 million ordinary shares to shareholders of state-owned legal person shares, including1350,000 shares to shareholders of public shares.

According to the resolution of the company's 2002 annual general meeting of shareholders, in 2003, the company implemented the plan of transferring the capital reserve to 6 shares for every 65,438+00 shares, increasing the registered capital by 78,265,438+00,000 shares (with a par value of 65,438+0 yuan per share). The registered capital of the changed company is RMB 208,560,000, which has been verified and issued by Xinyong Zhonghe Certified Public Accountants.

With the approval of the Ministry of Finance, after the implementation of the plan of transferring 6 shares of capital reserve for every 65,438+00 shares in 2002, China Technology Group Company, the former controlling shareholder of the company, transferred 70.08% of its state-owned legal person shares to China General Technology (Group) Holding Co., Ltd. (hereinafter referred to as "General Technology Group") for free.

According to the resolutions of the first extraordinary shareholders' meeting in 2006 and the shareholders' meeting related to the share-trading reform, the company implemented the share-trading reform in this period, with the capital reserve fund increasing by 4.9 1 share for every 1 share with a par value of1yuan. After the share transfer is completed, all non-tradable shares of the company will be listed and circulated, and this share-trading reform has been approved by the State-owned Assets Supervision and Administration Commission of the State Council (SASAC [2006] No.604). After the implementation of the share-trading reform plan, the registered capital of the company increased by 30,638,400 yuan, and the registered capital after the change was 23,965,438,000 yuan+098,400 yuan.

As of June 65438+February 3, 20071day, the company's total share capital was 239 198400 shares, which was held by General Technology Group and listed on the Shanghai Stock Exchange.

China Tektronix Trading Co., Ltd. was officially renamed as China Medicine and Health Products Co., Ltd. on February 20th, 2007. The shareholder code of the Company in Shanghai Stock Exchange remains unchanged at 600056.